Epinephrine Delivery System

A 2018 study by the Univ. of Southern California showed that half of adults with severe food allergies haven't had their EpiPen® or other auto-injector with them during their most severe attack. 

Dr. Edmund Pribitkin, CMO of Thomas Jefferson University Hospitals, approached Smithwise with a proposed solution--embedding an auto-injector for epinephrine into the case of a smartphone. 

This project is based on an issued US patent held by Thomas Jefferson University, US 10,022,506.

Jefferson is currently pursuing partnership opportunities for this device. For further information, please click here.





"Partnering with Smithwise was extraordinarily gratifying—their engineering know-how brought our product from patent to prototype in record time and with refinements that will improve patient safety and increase consumer adoption."


Edmund Pribitkin, MD, MBA

Chief Medical Officer, Thomas Jefferson University Hospital

Subscribe to MedTech Mindset!

Receive the latest industry insights, news, podcasts, videos, and events for the medtech audience from your friends at Smithwise + Catapult (average 2 emails monthly).

MedTech Leaders Trust Smithwise + Catapult